Need an investment idea? Check out Popular Stocks and S2O Stock Screener.

Market Price

21.18 

-0.03 -0.1%

as of Aug 22 '19

52 Week Range:

16.61 34.19


Stock Analyzer Tutorials

S2O Stock Analyzer - General Info

General Info


type: video (mp4); length: 3:30

Demonstrates how to use Stock Analyzer, shows how to analyze a stock and explains in detail "General Info" section of the Stock Analyzer result page.

S2O Stock Analyzer - Financial Statements

Financial Statements


type: video (mp4); length: 5:10

Explains information presented in the Financial Statements section of the S2O Stock Analyzer: financial statements charts, absolute values and growth rates.

S2O Stock Analyzer - Growth Grade and Financial Ratios

Growth Grade and Financial Ratios


type: video (mp4); length: 5:09

Demonstrates how to use Growth Grade & Financial Ratios section; shows the difference between historical and year-over-year Growth Grade on the real life example.

S2O Stock Analyzer - Value Price

Value Price


type: video (mp4); length: 6:03

Demonstrates how to use Value Price (intrinsic value) and the Graham Number, MOS (margin of safety) and IRT - Investment Recovery Time; explains 3 different projection models used to compute value price - pessimistic, moderate and optimistic.

S2O Stock Analyzer - Price Charts

Price Charts


type: video (mp4); length: 8:34

Demonstrates basic rules of how to read a candlestick chart, long and short term moving averages, stochastic, MACD and relative strength (RS) charts. Explains how bull or bear market condition is computed.

General Info

Tenet Healthcare Corporation operates as a diversified healthcare services company. The company operates in three segments: Hospital Operations and Other, Ambulatory Care, and Conifer. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies. The company also provides intensive and critical care, and coronary care units; physical therapy, orthopedic, oncology, and outpatient services; cardiothoracic surgery, neonatal intensive care, and neurosurgery services; quaternary care in heart, liver, kidney, and bone marrow transplants areas; tertiary and quaternary pediatric, and burn services; and limb-salvaging vascular procedures, acute level 1 trauma services, intravascular stroke care, minimally invasive cardiac valve replacement, imaging technology, and telemedicine access for various medical specialties. In addition, it operates ambulatory surgery and urgent care centers, imaging centers, and surgical hospitals; and offers healthcare business process services in the areas of hospital and physician revenue cycle management, as well as value-based care solutions to healthcare systems, individual hospitals, physician practices, self-insured organizations, health plans, and other entities. As of December 31, 2018, the company operated 68 hospitals, 23 surgical hospitals, and approximately 475 outpatient centers, as well as 255 ambulatory surgery, 36 urgent care, and 23 imaging centers in the United States. Tenet Healthcare Corporation was founded in 1967 and is headquartered in Dallas, Texas.

Financial Statements

The charts below show selected Annual and Quarterly Financial Data.

The purpose of these charts is to discover long and short term change dynamics. When numbers are growing year after year in the annual statements chart, the business become stronger and stronger and this is a good sign.

Quarterly Data Chart can be used to do a short term analysis. It makes sense to pay attention to the quarterly dynamics and do not wait for the next yearly statement. We should be alerted if we see that quarterly numbers are going down.

You can check "Annual Financial Statements" and "Quarterly Financial Statements" sections for exact numbers and growth rates.

Annual Statements

On a charts below the Line shows absolute values and the Bar chart shows Year-Over-Year Growth Rate for selected financial statement item. A consistent GROWTH is generally considered necessary to fund future growth from within a business.
NOTE: Growth Rate is not provided if either the latest period or the year-ago period contains a net loss. (source: WSJ Digest of Earnings)
TIP! move your mouse pointer over bar or a circle on any chart below to see details.

Financial Statements

Income Statement



 

Cash Flow Statement



 

Balance Sheet



 

Liquidity Ratios

Current Ratio


 

Current Ratio measures the ability to meet short term obligations. Generally accepted standard is 2 (current assets should be 2 times or 200% of current liabilities).

Quick Ratio


 

Measures immediate liquidity or the cash available to cover immediate liabilities. A safe margin would be at least 1 (100%).

Financial Leverage


 

Defined as total assets divided by total shareholders' equity. The higher the ratio, the more debt a company uses in its capital structure.

Profitability Ratios

ROA


 

Return on Assets (ROA) measures the income (profit) that is generated by the use of the assets of the business.

ROE


 

Return on Equity (ROE) is a measure of profitability that calculates how many dollars of profit a company generates with each dollar of shareholders equity. ROE is sometimes called "return on net worth."

ROIC


 

The Return on Invested Capital (ROIC) measure gives a sense of how well a company is using its money to generate returns. Some investors use this figure as a final evaluation to determine whether or not to invest in a company.

Annual Statements

Item Name Dec '08 Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18
Equity (BVPS) 0.86
2.59
11.79
13.15
10.92
8.52
7.47
8.14
5.30
0.24
-1.05
growth rate 201.2% 355.2% 11.5% -17.0% -22.0% -12.3% 9.0% -34.9% -95.5% -100.0%
Earnings BIT 37.00
205.00
158.00
161.00
334.00
-158.00
1,091.00
1,401.00
1,713.00
1,661.00
1,989.00
growth rate 454.1% -22.9% 1.9% 107.5% -100.0% 100.0% 28.4% 22.3% -3.0% 19.8%
Avg.PE 8.85
12.53
3.33
39.53
19.08
-64.97
382.64
145.91
145.91
-6.85
-6.85
growth rate 41.6% -73.4% 1,087.1% -51.7% -100.0% 100.0% -61.9% 0.0% -100.0% 0.0%
ROA 0.30
2.24
13.60
0.68
1.61
-1.06
0.07
-0.67
-0.79
-2.93
0.48
growth rate 646.7% 507.1% -95.0% 136.8% -100.0% 100.0% -100.0% 0.0% 0.0% 100.0%
ROE 31.85
87.23
128.33
4.60
12.63
-14.12
1.71
-20.86
-34.66
-521.48
growth rate 173.9% 47.1% -96.4% 174.6% -100.0% 100.0% -100.0% 0.0% 0.0%
ROIC 6.11
12.17
27.67
5.32
6.73
1.94
4.28
2.94
3.38
-0.57
growth rate 99.2% 127.4% -80.8% 26.5% -71.2% 120.6% -31.3% 15.0% -100.0%
Cur. Ratio 1.39
1.39
1.34
1.30
1.52
1.27
1.32
1.20
1.30
1.29
1.20
growth rate 0.0% -3.6% -3.0% 16.9% -16.5% 3.9% -9.1% 8.3% -0.8% -7.0%
Quick Ratio 1.06
1.14
0.91
0.86
0.97
0.73
0.73
0.71
0.90
0.75
0.78
growth rate 7.6% -20.2% -5.5% 12.8% -24.7% 0.0% -2.7% 26.8% -16.7% 4.0%
Leverage 79.36
25.49
5.94
7.77
7.91
21.36
27.87
34.27
59.23
growth rate -67.9% -76.7% 30.8% 1.8% 170.0% 30.5% 23.0% 72.8%
Balance Sheet Dec '08 Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18
Acct.Receivable 1,337.00
1,158.00
1,143.00
1,703.00
1,706.00
2,582.00
2,802.00
3,095.00
3,436.00
3,030.00
3,114.00
growth rate -13.4% -1.3% 49.0% 0.2% 51.4% 8.5% 10.5% 11.0% -11.8% 2.8%
Acct.Payable 1,248.00
1,262.00
1,905.00
1,179.00
1,380.00
1,329.00
1,175.00
1,207.00
growth rate 1.1% 51.0% -38.1% 17.1% -3.7% -11.6% 2.7%
Cur.Assets 2,709.00
2,472.00
2,311.00
2,357.00
2,681.00
3,692.00
3,970.00
5,171.00
5,257.00
5,573.00
4,636.00
growth rate -8.8% -6.5% 2.0% 13.8% 37.7% 7.5% 30.3% 1.7% 6.0% -16.8%
Total Assets 8,174.00
7,953.00
8,500.00
8,462.00
9,044.00
16,450.00
17,951.00
23,682.00
24,701.00
23,385.00
22,409.00
growth rate -2.7% 6.9% -0.5% 6.9% 81.9% 9.1% 31.9% 4.3% -5.3% -4.2%
Cash 507.00
690.00
405.00
113.00
364.00
113.00
193.00
356.00
716.00
611.00
411.00
growth rate 36.1% -41.3% -72.1% 222.1% -69.0% 70.8% 84.5% 101.1% -14.7% -32.7%
Inventory 161.00
153.00
156.00
161.00
153.00
260.00
276.00
309.00
326.00
289.00
305.00
growth rate -5.0% 2.0% 3.2% -5.0% 69.9% 6.2% 12.0% 5.5% -11.4% 5.5%
Cur.Liabilities 1,949.00
1,783.00
1,725.00
1,815.00
1,763.00
3,093.00
3,577.00
4,308.00
4,034.00
4,332.00
3,857.00
growth rate -8.5% -3.3% 5.2% -2.9% 75.4% 15.7% 20.4% -6.4% 7.4% -11.0%
Liabilities 8,071.00
7,307.00
6,734.00
7,023.00
7,885.00
15,355.00
16,765.00
20,458.00
21,226.00
20,980.00
20,302.00
growth rate -9.5% -7.8% 4.3% 12.3% 94.7% 9.2% 22.0% 3.8% -1.2% -3.2%
LT Debt 4,778.00
4,272.00
3,997.00
4,294.00
5,158.00
10,696.00
11,505.00
14,383.00
15,064.00
14,791.00
14,644.00
growth rate -10.6% -6.4% 7.4% 20.1% 107.4% 7.6% 25.0% 4.7% -1.8% -1.0%
Equity 103.00
646.00
1,766.00
1,423.00
1,143.00
755.00
651.00
691.00
417.00
-147.00
-119.00
growth rate 527.2% 173.4% -19.4% -19.7% -34.0% -13.8% 6.1% -39.7% -100.0% 0.0%
Common Shares 120.00
127.00
140.00
121.00
109.00
102.00
100.00
7.00
7.00
7.00
7.00
growth rate 5.8% 10.2% -13.6% -9.9% -6.4% -2.0% -93.0% 0.0% 0.0% 0.0%
Cash Flow Statement Dec '08 Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18
Capital Expenditures 387.00
235.00
457.00
475.00
508.00
691.00
933.00
842.00
875.00
707.00
617.00
growth rate -39.3% 94.5% 3.9% 7.0% 36.0% 35.0% -9.8% 3.9% -19.2% -12.7%
Cash Dividends 3.00
7.00
32.00
34.00
29.00
27.00
45.00
110.00
218.00
258.00
growth rate 133.3% 357.1% 6.3% -14.7% -6.9% 66.7% 144.4% 98.2% 18.4%
Cash From OA 208.00
425.00
472.00
497.00
593.00
589.00
687.00
1,026.00
558.00
1,200.00
1,049.00
growth rate 104.3% 11.1% 5.3% 19.3% -0.7% 16.6% 49.3% -45.6% 115.1% -12.6%
FCF per Share -2.83
-0.24
-0.03
0.04
0.78
0.42
-3.11
2.85
1.53
-3.36
6.51
growth rate 0.0% 0.0% 100.0% 1,850.0% -46.2% -100.0% 100.0% -46.3% -100.0% 100.0%
Sale Purchase of Stock -371.00
-404.00
-279.00
26.00
15.00
4.00
7.00
growth rate 0.0% 0.0% 100.0% -42.3% -73.3% 75.0%
FCF -339.00
-31.00
-4.00
22.00
85.00
-102.00
-246.00
184.00
-317.00
493.00
432.00
growth rate 0.0% 0.0% 100.0% 286.4% -100.0% 0.0% 100.0% -100.0% 100.0% -12.4%
Income Statement Dec '08 Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18
Sales 8,585.00
9,014.00
8,467.00
8,654.00
9,119.00
11,087.00
16,603.00
18,634.00
19,621.00
19,179.00
18,313.00
growth rate 5.0% -6.1% 2.2% 5.4% 21.6% 49.8% 12.2% 5.3% -2.3% -4.5%
Op.Income 311.00
538.00
634.00
103.00
209.00
-93.00
1,091.00
1,401.00
1,713.00
1,661.00
1,989.00
growth rate 73.0% 17.8% -83.8% 102.9% -100.0% 100.0% 28.4% 22.3% -3.0% 19.8%
IBT 54.00
205.00
158.00
164.00
334.00
-158.00
147.00
144.00
248.00
-101.00
639.00
growth rate 279.6% -22.9% 3.8% 103.7% -100.0% 100.0% -2.0% 72.2% -100.0% 100.0%
Net Income 25.00
187.00
1,143.00
103.00
209.00
-93.00
12.00
-140.00
-192.00
-704.00
111.00
growth rate 648.0% 511.2% -91.0% 102.9% -100.0% 100.0% -100.0% 0.0% 0.0% 100.0%
EPS 0.20
1.48
8.16
0.48
1.30
-1.32
0.12
-1.41
-1.93
-7.00
1.07
growth rate 640.0% 451.4% -94.1% 170.8% -100.0% 100.0% -100.0% 0.0% 0.0% 100.0%
Gross Profit 3,295.00
3,588.00
2,990.00
7,106.00
7,567.00
9,303.00
5,950.00
6,681.00
7,141.00
6,789.00
6,659.00
growth rate 8.9% -16.7% 137.7% 6.5% 22.9% -36.0% 12.3% 6.9% -4.9% -1.9%

Quarterly Statements

Item Name Mar '18 Jun '18 Sep '18 Dec '18 Mar '19
Earnings BIT 435.00
402.00
330.00
548.00
365.00
growth rate -7.6% -17.9% 66.1% -33.4%
Balance Sheet Mar '18 Jun '18 Sep '18 Dec '18 Mar '19
Acct.Receivable 3,121.00
2,913.00
2,908.00
3,114.00
3,303.00
growth rate -6.7% -0.2% 7.1% 6.1%
Acct.Payable 1,059.00
1,047.00
1,065.00
1,207.00
1,101.00
growth rate -1.1% 1.7% 13.3% -8.8%
Cur.Assets 5,634.00
4,705.00
4,492.00
4,636.00
4,582.00
growth rate -16.5% -4.5% 3.2% -1.2%
Total Assets 23,184.00
22,343.00
22,265.00
22,409.00
23,158.00
growth rate -3.6% -0.4% 0.7% 3.3%
Cash 974.00
403.00
500.00
411.00
252.00
growth rate -58.6% 24.1% -17.8% -38.7%
Inventory 294.00
298.00
307.00
305.00
308.00
growth rate 1.4% 3.0% -0.7% 1.0%
Cur.Liabilities 4,561.00
4,354.00
4,224.00
3,857.00
3,725.00
growth rate -4.5% -3.0% -8.7% -3.4%
Liabilities 20,626.00
20,338.00
20,163.00
20,302.00
21,045.00
growth rate -1.4% -0.9% 0.7% 3.7%
LT Debt 14,223.00
14,204.00
14,178.00
14,644.00
14,590.00
growth rate -0.1% -0.2% 3.3% -0.4%
Equity -65.00
-154.00
-108.00
-119.00
-134.00
growth rate 0.0% 0.0% 0.0% 0.0%
Common Shares 7.00
7.00
7.00
7.00
7.00
growth rate 0.0% 0.0% 0.0% 0.0%
Cash Flow Statement Mar '18 Jun '18 Sep '18 Dec '18 Mar '19
Capital Expenditures 143.00
125.00
136.00
213.00
192.00
growth rate -12.6% 8.8% 56.6% -9.9%
Cash Dividends 64.00
growth rate
Cash From OA 113.00
348.00
338.00
250.00
10.00
growth rate 208.0% -2.9% -26.0% -96.0%
Sale Purchase of Stock 9.00
5.00
growth rate -44.4%
FCF -30.00
223.00
202.00
37.00
-182.00
growth rate 100.0% -9.4% -81.7% -100.0%
Income Statement Mar '18 Jun '18 Sep '18 Dec '18 Mar '19
Sales 4,699.00
4,506.00
4,489.00
4,619.00
4,545.00
growth rate -4.1% -0.4% 2.9% -1.6%
Op.Income 435.00
402.00
330.00
548.00
365.00
growth rate -7.6% -17.9% 66.1% -33.4%
IBT 260.00
150.00
71.00
158.00
74.00
growth rate -42.3% -52.7% 122.5% -53.2%
Net Income 99.00
26.00
-9.00
-5.00
-19.00
growth rate -73.7% -100.0% 0.0% 0.0%
EPS
growth rate
Gross Profit 1,698.00
1,623.00
1,647.00
1,703.00
1,651.00
growth rate -4.4% 1.5% 3.4% -3.1%
R&D
growth rate

Growth Grade & Financial Ratios

All financial ratios below are calculated based on latest annual statements available and present the most up to date snapshot of a company finances.

Growth Grade

Historical Growth Grade:

E (30.27)

YOY Growth Grade:

E (17.64)

Click on buttons above for detailed yearly growth rates.

Market Ratios

Profitability Ratios

Liquidity Ratios

Efficiency Ratios

Value Price

Current EPS is negative, therefore value price cannot be calculated.

PE and EPS

Historical Current Forward
PE 22.68 -311.47 7.67
EPS / Growth -6.8% -0.07 24.0%

Value Price & Investment Recovery Time

Read more about Stock2Own value price in Stock Market: Fundamental Analysis.

Equity Growth Rate: 1.0%

Estimates Pessimistic Moderate Optimistic My Numbers
Rate of Return 15.0%
MOS Price % 50 %
Future EPS Growth 1.0% 1.0% 1.0%
Future PE 2.00 4.84 4.84
Future EPS 0.00 0.00 0.00
Value Price
MOS %
0.00
-100.0%
0.00
-100.0%
0.00
-100.0%
MOS Price 0.00 0.00 0.00
IRT 99.00 99.00 99.00

Graham Number:

Current EPS is negative, therefore Graham Number cannot be calculated.
NOTE: The Graham Number applies only to certain types of stocks in combination with a number of other criteria.

Read more about Graham Number in Stock Market: Fundamental Analysis.

Price Chart

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.

Risk / Reward Ratios

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.